Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$64.34 USD
-0.55 (-0.85%)
Updated Jun 12, 2024 04:00 PM ET
After-Market: $64.05 -0.29 (-0.45%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum A VGM
Brokerage Reports
0 items in cart
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 281 - 300 ( 525 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Announced its acquisition of Kite Pharma. for $180 per share or $11.9bn in cash
Provider: G.RESEARCH, LLC
Analyst: HE J
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.